The DOI matches its Crossref record.
Neuroinflammation, Oxidative Stress and the Pathogenesis of Alzheimers Disease
Abstract
Alzheimers disease (AD) is the most common neurodegenerative disorder that affects the elderly. The increase of lifeexpectancy is transforming AD into a major health-care problem. AD is characterized by a progressive impairment of memory and other cognitive skills leading to dementia. The major pathogenic factor associated to AD seems to be amyloid-beta peptide (Aβ) oligomers that tend to accumulate extracellularly as amyloid deposits and are associated with reactive microglia and astrocytes as well as with degeneration of neuronal processes. The involvement of microglia and astrocytes in the onset and progress of neurodegenerative process in AD is becoming increasingly recognized, albeit it is commonly accepted that neuroinflammation and oxidative stress can have both detrimental and beneficial influences on the neural tissue. However, little is known about the interplay of microglia, astrocytes and neurons in response to Aβ, especially in the early phases of AD. This review discusses current knowledge about the involvement of neuroinflammation in AD pathogenesis, focusing on phenotypic and functional responses of microglia, astrocytes and neurons in this process. The abnormal production by glia cells of pro-inflammatory cytokines, chemokines and the complement system, as well as reactive oxygen and nitrogen species, can disrupt nerve terminals activity causing dysfunction and loss of synapses, which correlates with memory decline; these are phenomena preceding the neuronal death associated with late stages of AD. Thus, therapeutic strategies directed at controlling the activation of microglia and astrocytes and the excessive production of pro-inflammatory and pro-oxidant factors may be valuable to control neurodegeneration in dementia. Keywords: Amyloid-beta, microglia, astrocytes, neurons, pro-inflammatory factors, reactive oxygen species, neurodegeneration, Alzheimer's disease, Dementia, Neuroinflammation, Pro-oxidant factors, Memory, Mild cognitive impairment, CNS, cytokines, prostaglandins, IL-1, PPAR-g, Complement system, Amyloid pla, Trophic factors, Glia-derived neurotrophic factor, Glial scars, Ca2+ overload, Homeostasis, Antioxidants, Electron transport chain, Curcumin, Quercetin
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, they have an impact on the unsaturated fatty acids chain of membrane phospholipids, causing cell lysis [116,117,118].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“This immune response causes both an invasion of the glia by circulating immune cells and the production of pro-inflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL) IL-1β and IL-6-, nitric oxide (NO), prostaglandin E2 (PGE2), chemokines, and ROS.”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“AD is also induced by neuroinflammation processes that occur as a brain immune barrier [117,154].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [117]
In the citing paper
“Oxidative stress associated with Aβ pathology plays an important role in the death of neurons in the AD brain [82,83,84,85].”
From Centella Asiatica Improves Memory and Promotes Antioxidative Signaling in 5XFAD Mice (2019) · cites this paper as [82]
Citations
Cited by
Sorted by citations
Items 201–300 of 678
Teixeira, F. C., Gutierres, J. M., Soares, M. S. P., de Mattos, B. D. S., Spohr, L., do Couto, C. A. T., Bona, N. P., Assmann, C. E., Morsch, V. M., da Cruz, I. B. M., et al. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05419-5 · Cited by 55
“Abnormal production of reactive oxygen and nitrogen species might lead to oxidative modification of biomolecules and disruption of nerve terminal activity causing alterations and loss of synapses (Agostinho et al. 2010).”
Diet quality and cognitive function in mid-aged and older men and women
Milte, C. M., Ball, K., Crawford, D. A., & McNaughton, S. A. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1326-5 · Cited by 56
“Oxidative stress and inflammation have also been implicated in Alzheimer’s disease [37] and can also be altered by dietary intake.”
BackgroundZhang, W., Bai, M., Ye, X., Hao, J., Zhang, Z., Su, C., Lei, G., Miao, J., & Li, Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.12.023 · Cited by 53
“Among numerous proinflammaory mediators associated with AD, IL-1 , IL-6, TNFa, and PGE2 in particular have been implicated in playing a pathogenic role in AD (Agostinho et al., 2010).”
BackgroundRetractedWang, W., Chen, X., Zhang, J., Zhao, Y., Li, S., Tan, L., Gao, J., Fang, X., & Luo, A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.11.001 · Cited by 53
Bioactive lignans from the rhizomes of Acorus gramineus.
Kim, K. H., Kim, H., Choi, S.-U., Moon, E., Kim, S., & Lee, K. (2011) · Journal of Natural Products · doi:10.1021/np200541m · Cited by 48
Chen, J., Yin, W. H., Tu, Y., Wang, S., Yang, X., Chen, Q., Zhang, X., Han, Y., & Pi, R. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.025 · Cited by 53
“…the incidence of AD (Jenkinson et al., 1989) and the interaction between reactive oxygen species and inflammation plays a pivotal role in AD (Agostinho et al., 2010; Quintanilla et al., 2012), both anti-inflammatory and antioxidant drugs might be benefit to the therapy of AD (Tan et al.,…”
BackgroundÖzdal, Z. D., Şahmetlioğlu, E., Narin, İ., & Cumaoğlu, A. (2019) · 3 Biotech · doi:10.1007/s13205-019-1739-z · Cited by 51
Potential Nutraceutical Properties of Leaves from Several Commonly Cultivated Plants
Amat-ur-Rasool, H., Symes, F., Tooth, D., Schaffert, L.-N., Elmorsy, E. M., Ahmed, M., Hasnain, S., & Carter, W. G. (2020) · Biomolecules · doi:10.3390/biom10111556 · Cited by 55
“Induction of oxidative stress and neuro-inflammation have also been proposed to contribute to brain damage in AD [21,22].”
BackgroundCurcumin: a natural substance with potential efficacy in Alzheimer’s disease
Potter, P. E. (2013) · Journal of Experimental Pharmacology · doi:10.2147/jep.s26803 · Cited by 51
“27,28 β 39–41 This has led to the suggestion that treatment with anti-inflammatory agents or drugs that reduce oxidative stress could be useful in the prevention or treatment of AD.”
Knezović, A., Loncar, A., Homolak, J., Smailović, U., Barilar, J. O., Ganoci, L., Božina, N., Riederer, P. F., & Šalković‐Petrišić, M. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1727-6 · Cited by 51
Altered DNA repair; an early pathogenic pathway in Alzheimer’s disease and obesity
Yu, H., Harrison, F. E., & Xia, F. (2018) · Scientific Reports · doi:10.1038/s41598-018-23644-4 · Cited by 50
Folch, J., Patraca, I., Martínez, N., Pedrós, I., Petrov, D., Ettcheto, M., Abad, S., Marin, M., Beas-Zarate, C., & Camins, A. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.05.002 · Cited by 48
Expression of Ambra1 in mouse brain during physiological and Alzheimer type aging
Sepe, S., Nardacci, R., Fanelli, F., Rosso, P., Bernardi, C., Cecconi, F., Mastroberardino, P. G., Piacentini, M., & Moreno, S. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.07.001 · Cited by 41
“Late in the pathology, Ambra1, Beclin1, and LC3II levels significantly increase, possibly as an attempt to cope with severe neuronal damage, consequent to oxidative stress and amyloid plaque deposition (Agostinho et al., 2010).”
BackgroundLi, C., Ren, J., Zhang, M., Wang, H., Fang, Y., Wu, J., & Tang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04536-3 · Cited by 52
“Studies have shown that the accumulation of misfolded proteins may be the main cause of microglial activation [33, 34].”
BackgroundCho, K. H., Kim, D., Yoon, C., Ko, W., Lee, S. J., Sohn, J. H., Jang, J., Ahn, J. S., Kim, Y., & Oh, H. (2015) · Neurochemistry International · doi:10.1016/j.neuint.2015.12.010 · Cited by 48
Shahbaz, S. K., Koushki, K., Sathyapalan, T., Majeed, M., & Sahebkar, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210823103020 · Cited by 50
“, interleukin (IL)-6, IL-1B) and neurotoxic factors like Reactive Oxidative Species (ROS) and Tumor Necrosis Factor (TNF-B)) which contribute to neuronal damage [6, 7].”
BackgroundInflammation and neurodegenerative disorders
Baune, B. T. (2015) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000140 · Cited by 49
“Several factors such as genetic predisposition [22,23], reduced synthesis of excitatory neurotransmitter acetylcholine [24], extracellular deposition of amyloid b in the brain [25], abnormalities in tau protein forming neurofibrillary tangles leading to disintegration of microtubules [26] and oxidative stress and infl…”
BackgroundCalió, M. L., Mosini, A. C., Marinho, D. S., Salles, G. N., Massinhani, F. H., Ko, G. M., & Porcionatto, M. A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105219 · Cited by 48
“Reactive astrocytes play critical roles in modulating neuroinflammation and oxidative stress, which are among the main aspects of the pathogenesis of AD (Agostinho et al., 2010).”
BackgroundFernandes, L. M. P., Cartágenes, S. C., Barros, M. A., Carvalheiro, T. C. V. S., Castro, N. C. F., Schamne, M. G., Lima, R. R., Prediger, R. D., Monteiro, M. C., Fontes-Júnior, E. A., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.05.007 · Cited by 46
Self-citationAcetylcholine suppresses microglial inflammatory response via α7nAChR to protect hippocampal neurons
Lin, L., Liu, Z., Jiang, Y.-Y., Shen, W., Peng, Y.-P., & Qiu, Y. (2019) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2019.01.114 · Cited by 46
“Introduction Neuroinflammation has been demonstrated to play an important role in the neurodegeneration process of Alzheimer's disease (AD), a disease considered to be the most common neurodegenerative disorder of ageing (Depino et al., 2003; Agostinho et al., 2010; Sadigh-Eteghad et al., 2015b).”
BackgroundBarber, K., Mendonca, P., & Soliman, K. F. A. (2023) · Brain Sciences · doi:10.3390/brainsci13010145 · Cited by 51
“Not only because of concerns about the side effects of conventional medicine but also because natural products are comparatively inexpensive and typically readily available in an ingestible form, there has been a rapid growth in interest in naturally occurring phytochemical compounds with antioxidant and neuroprotecti…”
BackgroundZhong, J., Wang, F., Wang, Z., Shen, C., Zheng, Y., Ma, F., Zhu, T., Chen, L., Tang, Q., & Zhu, J. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.050 · Cited by 47
Ruthirakuhan, M. T., Herrmann, N., Andreazza, A. C., Verhoeff, N. P. L. G., Gallagher, D., Black, S. E., Kiss, A., & Lanctôt, K. L. (2019) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988719874118 · Cited by 48
“One cross-sectional study reported that the anti-inflammatory cytokine, IL-10, was negatively correlated with agitation severity and thus may be a diagnostic marker of agitation.55 Two longitudinal studies reported on the monitoring capacity of TNF-a31 and IL-1b,33 as changes in these markers were positively correlate…”
BackgroundInfluentialThe Role of Glyoxalase in Glycation and Carbonyl Stress Induced Metabolic Disorders
Saeed, M., Kausar, M. A., Singh, R. K., Siddiqui, A. J., & Akhter, A. (2020) · Current Protein and Peptide Science · doi:10.2174/1389203721666200505101734 · Cited by 47
Pasban-Aliabadi, H., Esmaeili‐Mahani, S., & Abbasnejad, M. (2016) · Rejuvenation Research · doi:10.1089/rej.2016.1836 · Cited by 45
Yadav, M., Jindal, D. K., Dhingra, M. S., Kumar, A., Parle, M., & Dhingra, S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0366-8 · Cited by 46
“Oxidative stress is well known to produce neuroinflammation and vice versa (Mosley et al. 2006; Agostinho et al. 2010).”
BackgroundRecent advances in pharmacological research on Ecklonia species: a review
Koirala, P., Jung, H. A., & Choi, J. S. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0948-4 · Cited by 48
“Human cells have an inherited antioxidative defense system in the form of various enzymatic and non-enzymatic pathways for removing ROS. Elevated production of ROS increases oxidative stress, leading to cellular dysfunction, and it can eventually contribute to many pathological conditions, including neurological disor…”
BackgroundKhan, M. S., Ikram, M. A., Park, T. J., & Kim, M. O. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4051207 · Cited by 46
Flavonoid-Based Nanomedicines in Alzheimer’s Disease Therapeutics: Promises Made, a Long Way To Go
Prasanna, P., & Upadhyay, A. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00224 · Cited by 48
A Single Neurotoxic Dose of Methamphetamine Induces a Long-Lasting Depressive-Like Behaviour in Mice
Silva, C., Neves, A. F., Dias, A. I., de Freitas, H. J. F., Mendes, S. M., Pita, I. R., Viana, S., de Oliveira, P. A., Cunha, R. A., Ribeiro, C., et al. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9423-2 · Cited by 43
“2008; Sanacora and Banasr 2013) in view of the impact of modified astrocytic function on processes ranging from metabolic support, ion homeostasis, control of oxidative stress, of synaptic plasticity and global processes such as sleep or memory (Agostinho et al. 2010; Allaman et al. 2011; Kimelberg and Nedergaard 2010…”
BackgroundSelf-citationAstiz, M., Acaz‐Fonseca, E., & García‐Segura, L. M. (2013) · Neurotoxicity Research · doi:10.1007/s12640-013-9417-0 · Cited by 43
Yu, T., Guo, J., Zhu, S., Zhang, X., Zhu, Z. Z., Cheng, S., & Cong, X. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104277 · Cited by 42
Blood Ammonia as a Possible Etiological Agent for Alzheimer’s Disease
Jin, Y., Singh, P., & Chung, H. (2018) · Nutrients · doi:10.3390/nu10050564 · Cited by 42
“AD have not been successful in spite of serious scientific effort and still remains a most intractable scientific challenge [4,5].”
BackgroundPotential of Sorghum Polyphenols to Prevent and Treat Alzheimer’s Disease: A Review Article
Rezaee, N., Fernando, W. M. A. D. B., Hone, E., Sohrabi, H. R., Johnson, S. K., Gunzburg, S. T., & Martins, R. N. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.729949 · Cited by 46
Role of Stress, Depression, and Aging in Cognitive Decline and Alzheimer’s Disease
Daulatzai, M. A. (2014) · Current topics in behavioral neurosciences · doi:10.1007/7854_2014_350 · Cited by 42
“2010), and are implicated in the etiopathogenesis of AD (Engelhart et al. 2004; Griffin 2006; Parachikovaa et al. 2007; Agostinho et al. 2010; Hoozemans et al. 2011; Eikelenboom et al. 2010, 2011, 2012).”
BackgroundInfluentialUpdate on the Role of Cannabinoid Receptors after Ischemic Stroke
Capettini, L. D. S. A., Savergnini, S. Q., da Silva, R., Stergiopulos, N., Santos, R. A. S., Mach, F., & Montecucco, F. (2012) · Mediators of Inflammation · doi:10.1155/2012/824093 · Cited by 41
“Together with the acute leukocyte influx, these neuronal modifications are probably the most relevant events in the pathophysiology of cerebral ischemia/reperfusion [107, 108].”
BackgroundTerazawa, R., Akimoto, N., Kato, T., Itoh, T., Fujita, Y., Hamada, N., Deguchi, T., Iinuma, M., Noda, M., Nozawa, Y., et al. (2013) · Pharmacological Research · doi:10.1016/j.phrs.2013.02.002 · Cited by 40
“[1] Agostinho P, Cunha RA, Oliveira C.”
BackgroundGoel, R., Bhat, S. A., Hanif, K., Nath, C., & Shukla, R. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00274 · Cited by 40
Emokpae, O., Ben‐Azu, B., Ajayi, A. M., & Umukoro, S. (2020) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-019-01805-0 · Cited by 41
Wen, L.-Y., Wan, L., Lai, J., Chen, C. S., Chen, J. J.-Y., Wu, M.-Y., Hu, K.-C., Chiu, L., Tien, P., & Lin, H.-J. (2021) · PLoS ONE · doi:10.1371/journal.pone.0250440 · Cited by 43
Porcellotti, S., Fanelli, F., Fracassi, A., Sepe, S., Cecconi, F., Bernardi, C., Cimini, A., Cerù, M. P., & Moreno, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/967203 · Cited by 41
Quantitative proteomics of synaptosome S‐nitrosylation in Alzheimer’s disease
Wijasa, T. S., Sylvester, M., Brocke‐Ahmadinejad, N., Schwartz, S., Santarelli, F., Gieselmann, V., Klockgether, T., Brosseron, F., & Heneka, M. T. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14870 · Cited by 41
Zaręba-Kozioł, M., Szwajda, A., Dadlez, M., Wysłouch-Cieszyńska, A., & Lalowski, M. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036079 · Cited by 39
Ghoneim, M. M., & Block, R. I. (2012) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e328356bd6e · Cited by 40
Wang, W., Zhang, L., Zhang, X., Xue, R., Li, L., Zhao, W., Fu, Q., Mi, W., & Li, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00384 · Cited by 40
“Neuroinflammation plays pivotal roles in the neuropathogenesis of diseases with cognitive impairment, such as Alzheimer’s disease (AD; Agostinho et al., 2010) and postoperative cognitive dysfunction (POCD; Wan et al., 2007).”
BackgroundBirnie‐Gauvin, K., Peiman, K. S., Larsen, M. H., Aarestrup, K., Willmore, W. G., & Cooke, S. J. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.155465 · Cited by 41
“It has been hypothesized that prolonged secretion of GCs results in increased oxidative stress levels (Agostinho et al., 2010), and thus oxidative stress may provide a potential mechanism for the costs associated with chronic stress (Costantini et al., 2011).”
BackgroundLiu, T., Chen, S., Du, J., Xing, S., Li, R., & Li, Z. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113973 · Cited by 46
Singh, N., Bansal, Y., Bhandari, R., Marwaha, L., Singh, R., Chopra, K., & Kuhad, A. (2017) · Pharmacology · doi:10.1159/000453580 · Cited by 40
He, B., Xu, F., Yan, T., Xiao, F., Wu, B., Wang, Y., Bi, K., & Jia, Y. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.002 · Cited by 41
“Cholinergic dysfunction and oxidative stress contribute to Aβ-induced neurotoxicity (Craig et al., 2011; Agostinho et al., 2010).”
BackgroundAlbrakati, A., Albarakati, A. J. A., Lokman, M. S., Theyab, A., Algahtani, M., Menshawi, S. A., Alamri, O., omairi, N. E. A., Essawy, E. A.-R., Kassab, R. B., et al. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00300-2 · Cited by 39
Madeira, D., Dias, L., Santos, P. I., Cunha, R. A., Canas, P. M., & Agostinho, P. M. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02538-z · Cited by 44
Self-citationMetabolic Dysfunction of Astrocyte: An Initiating Factor in Beta-amyloid Pathology?
Yan, L., Xiao, M., Chen, R., & Cai, Z. (2013) · PubMed · Cited by 39
Yoon, C.-S., Kim, D.-C., Park, J.-S., Kim, K.-W., Kim, Y.-C., & Oh, H. (2018) · Molecules · doi:10.3390/molecules23092367 · Cited by 31
“In the nucleus, the NF-κB dimer binds to its DNA binding site, the κB site, leading to the transcription of a number of genes that includes those coding for adhesion molecules, chemokine-inducible enzymes, and pro-inflammatory mediators like interferon-gamma (IFN-γ), NO, TNF-α, and PGE2 [20].”
BackgroundGo, R. C. P., Corley, M. J., Ross, G. W., Petrovitch, H., Masaki, K., Maunakea, A. K., He, Q., & Tiirikainen, M. (2020) · BMC Neuroscience · doi:10.1186/s12868-020-00582-4 · Cited by 39
Joshi, P., Bisht, A., Joshi, S., Semwal, D. K., Nema, N. K., Dwivedi, J., & Sharma, S. K. (2022) · Phytotherapy Research · doi:10.1002/ptr.7522 · Cited by 39
Kruk-Słomka, M., Boguszewska‐Czubara, A., Słomka, T., Budzyńska, B., & Biała, G. (2015) · Neural Plasticity · doi:10.1155/2016/9815092 · Cited by 37
“Moreover, malondialdehyde (MDA), the product of lipid peroxidation, is a neuronal toxin and may impair protein function [4].”
BackgroundGlia and TRPM2 Channels in Plasticity of Central Nervous System and Alzheimer’s Diseases
Wang, J., Jackson, M. F., & Xie, Y. (2016) · Neural Plasticity · doi:10.1155/2016/1680905 · Cited by 35
“These neuropathological changes are associated with not only the roles played by neurons but also the activation of glial cells (mainly including microglia and astrocytes) and the interaction between neurons and glial cells [1, 2].”
BackgroundVitamin E and Alzheimer’s Disease—Is It Time for Personalized Medicine?
Cervantes, B. R., & Ulatowski, L. M. (2017) · Antioxidants · doi:10.3390/antiox6030045 · Cited by 37
“More recently, the contribution of oxidative stress has become increasingly recognized and investigated in the context of AD etiology [24,25].”
BackgroundChuang, K., Li, M., Lin, N., Chang, C.-H., Lu, I.-H., Pan, I.-H., Takahashi, T., Perng, M., & Wen, S. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/5414297 · Cited by 40
“These mediators may directly induce neuronal apoptosis or amplify the local inflammatory response, which leads to possible synaptic dysfunction or neuronal loss [16].”
BackgroundKaur, G., & Prakash, A. K. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108255 · Cited by 36
Qian, X., Zhang, S., Duan, L., Yang, F., Zhang, K., Yan, F., & Ge, S. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201007 · Cited by 42
Bian, X., Yang, L., Jiang, D., Grippin, A., Ma, Y., Wu, S., Wu, L., Wang, X., Tang, Z., Tang, K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48461-4 · Cited by 41
Medicinally Privileged Natural Chalcones: Abundance, Mechanisms of Action, and Clinical Trials
Villa, S. M., Heckman, J. E., & Bandyopadhyay, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179623 · Cited by 36
“Cardamonin has the potential to reduce microglia-derived oxidative stress [57].”
BackgroundBrain RNA-Seq Profiling of the Mucopolysaccharidosis Type II Mouse Model
Salvalaio, M., D’Avanzo, F., Rigon, L., Zanetti, A., D’Angelo, M., Valle, G., Scarpa, M., & Tomanin, R. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051072 · Cited by 37
Diminished stress resistance and defective adaptive homeostasis in age-related diseases
Lomeli, N., Bota, D. A., & Davies, K. J. A. (2017) · Clinical Science · doi:10.1042/cs20160982 · Cited by 39
Fang, Y., Xia, W., Cheng, B. H., Hua, P., Zhou, H., Gu, Q., & Xu, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.02.063 · Cited by 37
Role of melatonin in TLR4-mediated inflammatory pathway in the MTPT-induced mouse model
Yıldırım, S., Özkan, A., Aytaç, G., Ağar, A., & Tanrιöver, G. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.11.011 · Cited by 36
Xiao, S., Liu, Y.-J., Wang, L., Sha, Z., Che, X., Yu, Z., & Lee, S. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.875138 · Cited by 41
“…of NFT, overactivated astrocytes introduce perturbation to the CNS and cause damage to the surrounding neurons which results in the imbalance of immune-neuron homeostasis (Agostinho et al., 2010; Avila-Muñoz and Arias, 2014; Ahmad et al., 2019) and Aβ accumulation in both neurons and astrocytes.”
BackgroundElfakhri, K. H., Abdallah, I. M., Brannen, A. D., & Kaddoumi, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.01.020 · Cited by 36
“Furthermore, strong evidence suggests that neuroinflammation and oxidative stress significantly contribute to AD pathology and disease progression (Agostinho et al., 2010; De Felice and Lourenco, 2015).”
BackgroundLazarev, V. F., Nikotina, A. D., Semenyuk, P. I., Evstafeva, D., Mikhaylova, E. R., Muronetz, V. I., Shevtsov, M. A., Tolkacheva, A. V., Добродумов, А. В., Shavarda, A. L., et al. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.025 · Cited by 34
Karthivashan, G., Kweon, M.-H., Park, S.-Y., Kim, J.-S., Kim, D.-H., Ganesan, P., & Choi, D.-K. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.04.062 · Cited by 34
Song, X., Hu, J., Sun, M.-N., Li, Z., Zhu, Z., Song, L.-K., Yuan, Y., Liu, G., & Chen, N. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.05.002 · Cited by 34
Recent Studies on Protective Effects of Walnuts against Neuroinflammation
Tan, B., Wang, Y., Zhang, X., & Sun, X. (2022) · Nutrients · doi:10.3390/nu14204360 · Cited by 35
“Oxidative stress and inflammation also play pivotal roles in other brain disorders, such as Parkinson’s disease and several age-related chronic diseases [88,89].”
BackgroundTestosterone deficiency, insulin-resistant obesity and cognitive function
Pintana, H., Chattipakorn, N., & Chattipakorn, S. C. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9655-3 · Cited by 33
“In addition, neuroinflammation and oxidative stress are strongly associated with cognitive impairment (Agostinho et al. 2010; Pistell et al. 2010).”
Klinger, R. Y., James, O. G., Borges‐Neto, S., Bisanar, T. L., Li, Y., Qi, W., Berger, M., Terrando, N., Newman, M. F., Doraiswamy, P. M., et al. (2018) · Anesthesiology · doi:10.1097/aln.0000000000002103 · Cited by 33
“Cross-clamp time (min) 90 (34) 87 (33) 90 (30) 84 (34)”
Hofmann, J., Fayez, S., Scheiner, M., et al. (2020) · Chemistry - A European Journal · doi:10.1002/chem.202001264 · Cited by 33
Synaptosome as a tool in Alzheimer’s disease research
Ahmad, F., & Liu, P. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147009 · Cited by 33
Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer’s disease
Alavi, M. S., Fanoudi, S., Hosseini, M., & Sadeghnia, H. R. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00888-0 · Cited by 34
Caruso, G. (2022) · Molecules · doi:10.3390/molecules27103303 · Cited by 33
Neuronal glutathione loss leads to neurodegeneration involving gasdermin activation
Hashimoto, S., Matsuba, Y., Takahashi, M., Kamano, N., Watamura, N., Sasaguri, H., Takado, Y., Yoshihara, Y., Saito, T., & Saido, T. C. (2023) · Scientific Reports · doi:10.1038/s41598-023-27653-w · Cited by 36
Zhou, W., Zhong, G., Fu, S., Xie, H., Chi, T., Li, L., Rao, X., Zeng, S., Xu, D., Wang, H., et al. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00125 · Cited by 33
Alkaloids as Potential Multi-Target Drugs to Treat Alzheimer's Disease
Lima, J. A., & Hamerski, L. (2018) · Studies in natural products chemistry · doi:10.1016/b978-0-444-64183-0.00008-7 · Cited by 34
Sharma, Y., & Garabadu, D. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.08.020 · Cited by 31
Choi, J., Kim, S., Yoo, J. S., Kim, H. J., Kim, H. J., Kim, B. E., Lee, E. H., Lee, Y. S., Park, J., & Park, K. D. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.113103 · Cited by 34
Qin, X., Sun, Z.-Q., Zhang, X.-W., Dai, X., Mao, S., & Zhang, Y.-M. (2013) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-013-0247-6 · Cited by 32
“Mounting evidence indicates that the neurotoxicity of microglia activation contributes to neuronal damage in hypoxic–ischemic brain injury [1, 15].”
Missing Puzzle Pieces in Dementia Research: HCN Channels and Theta Oscillations
Kaźmierska, P., Jankowski, M. M., & MacIver, M. B. (2023) · Aging and Disease · doi:10.14336/ad.2023.0607 · Cited by 32
Ambeskovic, M., Hopkins, G., Hoover, T. D., Joseph, J. T., Montina, T., & Metz, G. A. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914769 · Cited by 33
“Links between AD pathology, oxidative stress, and inflammation are well documented [61,62] and suggest that AD is characterized by changes in the arginine–proline and glycerophospholipid metabolisms [19,22,26,63].”
BackgroundDual impact of neuroinflammation on cognitive and motor impairments in Alzheimer's disease
Fakorede, S., Lateef, O. M., Garuba, W. A., Akosile, P. O., Okon, D. A., & Aborode, A. T. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251341870 · Cited by 40
Liu, R., Huang, C., Bennett, D. A., Li, H., & Wang, R. (2016) · PubMed Central · Cited by 31
Solomon, U., & Eduviere, A. T. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.04.002 · Cited by 32
“…provokes oxidative stress and amplifies the ongoing inflammatory responses, thus propagating neuroinflammation that leads to progressive neurodegeneration and loss of cognitive functions in LPS-treated animals (Lee et al., 2008; Agostinho et al., 2010; Weintraub et al., 2013; Frühauf et al., 2015).”
Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease
Gaamouch, F. E., Liu, K., Lin, H., Wu, C., & Wang, J. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105046 · Cited by 31
Zhang, Z., Li, C., Zug, C., & Schluesener, H. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104616 · Cited by 33
Kalra, J., Kumar, P., Majeed, A. B. A., & Prakash, A. K. (2016) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2016.04.002 · Cited by 31
Adrenomedullin, a Novel Target for Neurodegenerative Diseases
Ferrero, H., Larráyoz, I. M., Gil-Bea, F. J., Martı́nez, A., & Ramírez, M. J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1031-y · Cited by 33
Potential neuroprotective effects of fermented foods and beverages in old age: a systematic review
Porras‐García, E., Calderón, I. F.-E., González, J. G., & Fernández‐García, J. C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1170841 · Cited by 39
Khan, G., Hussain, M. S., Khan, Y., Fatima, R., Ahmad, S., Sultana, A., & Alam, P. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149776 · Cited by 35
Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease
Štrac, D. Š., Konjevod, M., Perković, M. N., Tudor, L., Erjavec, G. N., & Pivac, N. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200317092310 · Cited by 31
Surfactin exhibits neuroprotective effects by inhibiting amyloid β-mediated microglial activation
Park, S. Y., Kim, J.-H., Lee, S. J., & Kim, Y. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.07.004 · Cited by 30
Ano, Y., Kutsukake, T., Hoshi, A., Yoshida, A., & Nakayama, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0116598 · Cited by 29
Vinpocetine mitigates aluminum-induced cognitive impairment in socially isolated rats
Ali, A. A., Ahmed, H. I., Khaleel, S. A., & Abu‐Elfotuh, K. (2019) · Physiology & Behavior · doi:10.1016/j.physbeh.2019.112571 · Cited by 31
Metadata
- Authors
- Agostinho, P., A. Cunha, R., & Oliveira, C.
- Affiliations
- University of Coimbra (PT)
- Corresponding author
- Oliveira, Catarina
- Venue
- Current Pharmaceutical Design
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-08-01
- Volume
- 16
- Issue
- 25
- Pages
- 2766-2778
- ISSN
- 1381-6128 (ISSN-L)
- OpenAlex
- W2114324710
- Cited by
- 685
- References
- 0
- Citations by year
- 2026: 35 · 2025: 44 · 2024: 46 · 2023: 43 · 2022: 52 · 2021: 61 · 2020: 58 · 2019: 42 · 2018: 44 · 2017: 51 · 2016: 32 · 2015: 36 · 2014: 34 · 2013: 37 · 2012: 41
- FWCI
- 20.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Pharmaceutical Design (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, neuroinflammation, oxidative stress, amyloid-beta oligomers, amyloid plaques, microglia, astrocytes, neurodegeneration, inflammatory cytokines, chemokines, complement system, reactive oxygen species, reactive nitrogen species, synaptic loss, memory impairment, mild cognitive impairment, glial activation, antioxidants, curcumin, quercetin, glial scar, calcium overload, PPARγ
- MeSH terms
- Alzheimer Disease, Animals, Antioxidants, Brain, Humans, Models, Neurological, Nerve Degeneration, Neuroglia, Drug Delivery Systems, Oxidative Stress, Inflammation Mediators
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review